
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF (MSOX)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: MSOX (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit -78.42% | Avg. Invested days 12 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) 244252 | Beta - | 52 Weeks Range 3.44 - 159.00 | Updated Date 04/2/2025 |
52 Weeks Range 3.44 - 159.00 | Updated Date 04/2/2025 |
Upturn AI SWOT
AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF
ETF Overview
Overview
The AdvisorShares MSOS 2x Daily ETF (MSOX) is a leveraged exchange-traded fund designed to deliver twice the daily performance of the AdvisorShares Pure US Cannabis ETF (MSOS). It focuses on U.S. cannabis companies, seeking to amplify gains (and losses) through its leveraged investment strategy.
Reputation and Reliability
AdvisorShares is known for its actively managed ETFs, including several cannabis-focused funds. Their reputation is built on providing niche and specialized investment products.
Management Expertise
AdvisorShares has a team with expertise in actively managing ETFs and a focus on emerging sectors like the cannabis industry.
Investment Objective
Goal
To seek daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the AdvisorShares Pure US Cannabis ETF (MSOS).
Investment Approach and Strategy
Strategy: The ETF employs a leveraged strategy, aiming to magnify the daily returns of its underlying index or assets. This is achieved through financial instruments like swaps or futures.
Composition The ETF's assets primarily consist of financial instruments designed to achieve its 2x leverage target on MSOS. It does not directly hold cannabis stocks, but uses derivatives to mimic the desired performance.
Market Position
Market Share: Limited data on exact market share available, as leveraged ETFs serve a different purpose than unleveraged funds.
Total Net Assets (AUM): 47651879
Competitors
Key Competitors
- AdvisorShares Pure US Cannabis ETF (MSOS)
- CANSLIM ETF (SLAM)
Competitive Landscape
The competitive landscape involves both direct cannabis ETFs and broader growth-oriented ETFs. MSOX differentiates itself through its 2x leveraged strategy, offering higher potential returns (and risks) compared to unleveraged cannabis ETFs like MSOS. This makes it a niche product for risk-tolerant investors.
Financial Performance
Historical Performance: Historical performance is highly dependent on the daily performance of MSOS, amplified by a factor of 2. Past performance is not indicative of future results, especially given the leveraged nature of the fund.
Benchmark Comparison: The ETF's performance should be compared to 2x the daily returns of MSOS. Tracking error may occur due to fees, expenses, and the complexities of maintaining leverage.
Expense Ratio: 1.55
Liquidity
Average Trading Volume
The average trading volume is moderate, indicating acceptable liquidity for most investors, but may fluctuate.
Bid-Ask Spread
The bid-ask spread can vary, particularly during periods of high volatility or low trading volume, potentially impacting trading costs.
Market Dynamics
Market Environment Factors
Economic conditions, regulatory changes in the cannabis industry, and overall market sentiment significantly impact MSOX's performance. Positive developments in cannabis legalization can drive up the value of MSOS and consequently MSOX.
Growth Trajectory
The growth trajectory depends on the U.S. cannabis market's expansion and regulatory environment. As more states legalize cannabis and federal regulations potentially ease, the underlying MSOS ETF and MSOX could experience significant growth. However, this growth is intertwined with regulatory risks.
Moat and Competitive Advantages
Competitive Edge
MSOX's primary competitive advantage is its 2x leveraged exposure to U.S. cannabis companies. This allows investors to potentially amplify their returns if they believe in the sector's short-term growth. This leveraged exposure provides a unique offering not found in traditional unleveraged cannabis ETFs. However, this leverage also amplifies losses, making it a higher-risk investment. The ETF's success hinges on accurately predicting the short-term movements of the U.S. cannabis market.
Risk Analysis
Volatility
MSOX exhibits significantly higher volatility due to its leveraged nature. Daily fluctuations are amplified, leading to greater potential gains and losses compared to unleveraged ETFs.
Market Risk
Market risk is substantial, as MSOX is heavily reliant on the performance of U.S. cannabis companies. Regulatory uncertainty, competition within the industry, and changes in market sentiment all contribute to the ETF's overall risk profile. Compounding risk comes from maintaining 2x leverage, causing the potential for amplified losses and rapid value erosion.
Investor Profile
Ideal Investor Profile
The ideal investor for MSOX is a risk-tolerant, active trader who has a strong understanding of the U.S. cannabis market and is comfortable with leveraged investments. They should have a short-term investment horizon and be prepared for significant price swings.
Market Risk
MSOX is best suited for active traders seeking short-term gains, not for long-term investors or passive index followers. Its leveraged nature makes it unsuitable for risk-averse individuals.
Summary
AdvisorShares MSOS 2x Daily ETF (MSOX) is a leveraged ETF designed to amplify the daily returns of the AdvisorShares Pure US Cannabis ETF (MSOS). It is suited for risk-tolerant, active traders who have a short-term investment horizon and are knowledgeable about the U.S. cannabis market. Its leveraged strategy allows for potentially higher returns, but also increases the risk of significant losses. This ETF is not recommended for long-term investors or those with low risk tolerance. Investors must carefully consider the risks associated with leveraged ETFs before investing.
Similar Companies
MJ

Amplify ETF Trust


MJ

Amplify ETF Trust
MSOS

AdvisorShares Pure US Cannabis ETF


MSOS

AdvisorShares Pure US Cannabis ETF
SLAM

Slam Corp


SLAM

Slam Corp
YOLO

AdvisorShares Pure Cannabis


YOLO

AdvisorShares Pure Cannabis
Sources and Disclaimers
Data Sources:
- AdvisorShares website
- SEC filings
- Various financial data providers
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Leveraged ETFs are not suitable for all investors and should be used with caution.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund will enter into one or more swap agreements intended to produce economically-leveraged investment results relative to the returns of the US Cannabis ETF. The US Cannabis ETF primarily invests in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.